Which of the following statements by the nurse about clomid as an ovulation inducing drug is correct?

Explanation

Core Concept: Clomiphene citrate (Clomid) is a selective estrogen receptor modulator (SERM) used to treat anovulatory infertility. By blocking estrogen receptors in the hypothalamus, it inhibits negative feedback, leading to increased secretion of GnRH, FSH, and LH. This robust stimulation can cause multiple ovarian follicles to mature and ovulate simultaneously, significantly increasing the risk of multiple gestations (e.g., twins or triplets).

Clinical Presentation:

• Indicated for women with oligo-ovulation or anovulation (e.g., Polycystic Ovary Syndrome).
• Side effects include hot flashes, mood swings, pelvic discomfort, and visual disturbances.
• Complications include Ovarian Hyperstimulation Syndrome (OHSS) and the medical/obstetric risks associated with multiple pregnancies (prematurity, low birth weight).

Diagnosis:

• First-line diagnostic tool: Transvaginal ultrasound to monitor follicular development and measure endometrial thickness during the treatment cycle.
• Gold standard diagnostic test: Comprehensive hormonal profiling and ovulation tracking (serum progesterone levels in the luteal phase) to confirm successful induction of ovulation.

Management:

• Acute management: Administering Clomid for 5 days early in the menstrual cycle (typically days 3-7 or 5-9) and timing intercourse or intrauterine insemination (IUI) based on follicular monitoring.
• Gold standard long-term/definitive management: If Clomid fails after 3-6 ovulatory cycles, transitioning to alternative therapies like Letrozole, injectable gonadotropins, or Assisted Reproductive Technologies (ART) such as In Vitro Fertilization (IVF).